ATNX Athenex Inc.

Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.

$0.41  -0.01 (-2.48%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  06/14/2017
Outstanding shares:  111,830,484
Average volume:  1,839,631
Market cap:   $46,946,437
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF04FC3
Valuation   (See tab for details)
PE ratio:   -0.24
PB ratio:   1.20
PS ratio:   0.43
Return on equity:   -507.59%
Net income %:   -177.11%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy